Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA

NCT06650592 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT06650592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06650592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Recruiting
Start date
November 26, 2024
Completion date
October 31, 2029
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic reconstruction